cosentyx - secukinumab injection
(Secukinumab)Novartis Pharmaceuticals Corporation
Usage: COSENTYX is indicated for treating moderate to severe plaque psoriasis, active psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis in children 4 years and older, and moderate to severe hidradenitis suppurativa in patients 12 years and older.